<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font14">with </span>
   <span class="font13">viral </span>
   <span class="font13">that </span>
   <span class="font13">(). </span>
   <span class="font13">for </span>
   <span class="font12">was </span>
   <span class="font12">virus </span>
   <span class="font12">favipiravir </span>
   <span class="font12">model </span>
   <span class="font12">treatment </span>
   <span class="font11">antiviral </span>
   <span class="font11">drug </span>
   <span class="font11">Ebola </span>
   <span class="font11">from </span>
   <span class="font11">infection </span>
   <span class="font11">cell </span>
   <span class="font11">are </span>
   <span class="font11">infected </span>
   <span class="font11">&amp;amp; </span>
   <span class="font11">this </span>
   <span class="font11">these </span>
   <span class="font11">were </span>
   <span class="font11">efficacy </span>
   <span class="font11">The </span>
   <span class="font11">cells </span>
   <span class="font11">patients </span>
   <span class="font11">peak </span>
   <span class="font11">{background </span>
   <span class="font11">rate </span>
   <span class="font11">than </span>
   <span class="font11">viremia </span>
   <span class="font11">against </span>
   <span class="font11">load </span>
   <span class="font10">could </span>
   <span class="font10">dynamics </span>
   <span class="font10">immune </span>
   <span class="font10">survival </span>
   <span class="font10">concentrations </span>
   <span class="font10">effect </span>
   <span class="font10">mg/kg </span>
   <span class="font10">not </span>
   <span class="font10">response </span>
   <span class="font10">treated </span>
   <span class="font10">which </span>
   <span class="font10">animals </span>
   <span class="font10">target </span>
   <span class="font10">can </span>
   <span class="font10">levels </span>
   <span class="font10">margin </span>
   <span class="font10">used </span>
   <span class="font10">This </span>
   <span class="font10">first </span>
   <span class="font10">models </span>
   <span class="font10">results </span>
   <span class="font10">{border-style </span>
   <span class="font10">JIKI </span>
   <span class="font10">been </span>
   <span class="font10">but </span>
   <span class="font10">days </span>
   <span class="font10">infection. </span>
   <span class="font10">clinical </span>
   <span class="font10">data </span>
   <span class="font10">during </span>
   <span class="font10">px;} </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">also </span>
   <span class="font10">b.i.d. </span>
   <span class="font10">day </span>
   <span class="font10">Figure </span>
   <span class="font10">after </span>
   <span class="font10">between </span>
   <span class="font10">doses </span>
   <span class="font10">dosing </span>
   <span class="font10">lower </span>
   <span class="font10">mice </span>
   <span class="font10">ribavirin </span>
   <span class="font10">where </span>
   <span class="font10">acute </span>
   <span class="font10">disease </span>
   <span class="font10">high </span>
   <span class="font10">infection, </span>
   <span class="font10">may </span>
   <span class="font10">observed </span>
   <span class="font10">obtained </span>
   <span class="font10">trial </span>
   <span class="font10">EBOV </span>
   <span class="font10">Lassa </span>
   <span class="font10">about </span>
   <span class="font10">found </span>
   <span class="font10">has </span>
   <span class="font10">have </span>
   <span class="font10">studies </span>
   <span class="font10">untreated </span>
   <span class="font10">use </span>
   <span class="font10">Zika </span>
   <span class="font10">cytokine </span>
   <span class="font10">macaques </span>
   <span class="font10">time </span>
   <span class="font10">using </span>
   <span class="font10">EVD </span>
   <span class="font10">associated </span>
   <span class="font10">concentration </span>
   <span class="font10">human </span>
   <span class="font10">influenza </span>
   <span class="font10">modeling </span>
   <span class="font10">more </span>
   <span class="font10">predicted </span>
   <span class="font10">virus, </span>
   <span class="font10">Dis., </span>
   <span class="font10">early </span>
   <span class="font10">fever </span>
   <span class="font10">innate </span>
   <span class="font10">into </span>
   <span class="font10">level </span>
   <span class="font10">number </span>
   <span class="font10">other </span>
   <span class="font10">regimen </span>
   <span class="font10">such </span>
   <span class="font10">those </span>
   <span class="font10">(Figure </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Med., </span>
   <span class="font10">achieve </span>
   <span class="font10">adaptive </span>
   <span class="font10">analysis </span>
   <span class="font10">cynomolgus </span>
   <span class="font10">cytokines </span>
   <span class="font10">initiated </span>
   <span class="font10">limited </span>
   <span class="font10">model, </span>
   <span class="font10">plasma </span>
   <span class="font10">reduce </span>
   <span class="font10">will </span>
   <span class="font10">Infect. </span>
   <span class="font10">NHP </span>
   <span class="font10">NHPs </span>
   <span class="font10">activity </span>
   <span class="font10">assuming </span>
   <span class="font10">cells, </span>
   <span class="font10">does </span>
   <span class="font10">estimated </span>
   <span class="font10">experiments </span>
   <span class="font10">increase </span>
   <span class="font10">initiation </span>
   <span class="font10">loss </span>
   <span class="font10">nonhuman </span>
   <span class="font10">only </span>
   <span class="font10">our </span>
   <span class="font10">several </span>
   <span class="font10">(.–.) </span>
   <span class="font10">However, </span>
   <span class="font10">IFNα </span>
   <span class="font10">Marburg </span>
   <span class="font10">PLoS </span>
   <span class="font10">Perelson, </span>
   <span class="font10">Rev. </span>
   <span class="font10">animal </span>
   <span class="font10">close </span>
   <span class="font10">compared </span>
   <span class="font10">context </span>
   <span class="font10">drugs </span>
   <span class="font10">effective </span>
   <span class="font10">expressing </span>
   <span class="font10">favipiravir, </span>
   <span class="font10">hepatitis </span>
   <span class="font10">including </span>
   <span class="font10">large </span>
   <span class="font10">larger </span>
   <span class="font10">leading </span>
   <span class="font10">model. </span>
   <span class="font10">most </span>
   <span class="font10">particular </span>
   <span class="font10">px; </span>
   <span class="font10">ref. </span>
   <span class="font10">replication </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">two </span>
   <span class="font10">what </span>
   <span class="font10">{font-family </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Given </span>
   <span class="font10">Nat. </span>
   <span class="font10">RNA </span>
   <span class="font10">Res., </span>
   <span class="font10">Thus, </span>
   <span class="font10">before </span>
   <span class="font10">better </span>
   <span class="font10">chronic </span>
   <span class="font10">fact </span>
   <span class="font10">following </span>
   <span class="font10">font-size </span>
   <span class="font10">given </span>
   <span class="font10">had </span>
   <span class="font10">kinetics </span>
   <span class="font10">mathematical </span>
   <span class="font10">needed </span>
   <span class="font10">outbreak </span>
   <span class="font10">production </span>
   <span class="font10">relevant </span>
   <span class="font10">reported </span>
   <span class="font10">response, </span>
   <span class="font10">role </span>
   <span class="font10">shown </span>
   <span class="font10">trial, </span>
   <span class="font10">values </span>
   <span class="font10">vitro </span>
   <span class="font10">(see </span>
   <span class="font10">Clin. </span>
   <span class="font10">IL, </span>
   <span class="font10">J., </span>
   <span class="font10">Mauritian </span>
   <span class="font10">Viral </span>
   <span class="font10">account </span>
   <span class="font10">achieved </span>
   <span class="font10">action </span>
   <span class="font10">available </span>
   <span class="font10">baseline </span>
   <span class="font10">basic </span>
   <span class="font10">benefit </span>
   <span class="font10">both </span>
   <span class="font10">combination </span>
   <span class="font10">developed </span>
   <span class="font10">development </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">effectiveness </span>
   <span class="font10">equal </span>
   <span class="font10">even </span>
   <span class="font10">exposure </span>
   <span class="font10">favipiravir. </span>
   <span class="font10">growth </span>
   <span class="font10">host </span>
   <span class="font10">how </span>
   <span class="font10">humans </span>
   <span class="font10">identify </span>
   <span class="font10">included </span>
   <span class="font10">involved </span>
   <span class="font10">its </span>
   <span class="font10">maximal </span>
   <span class="font10">models, </span>
   <span class="font10">much </span>
   <span class="font10">new </span>
   <span class="font10">noted </span>
   <span class="font10">parameters </span>
   <span class="font10">per </span>
   <span class="font10">predictions </span>
   <span class="font10">provided </span>
   <span class="font10">pro�?inflammatory </span>
   <span class="font10">receiving </span>
   <span class="font10">regimens </span>
   <span class="font10">remain </span>
   <span class="font10">respectively, </span>
   <span class="font10">significantly </span>
   <span class="font10">specific </span>
   <span class="font10">subsequent </span>
   <span class="font10">sufficient </span>
   <span class="font10">suggesting </span>
   <span class="font10">their </span>
   <span class="font10">three </span>
   <span class="font10">trial. </span>
   <span class="font10">value </span>
   <span class="font10">virus; </span>
   <span class="font10">when </span>
   <span class="font10">would </span>
   <span class="font10">(Eq. </span>
   <span class="font10">(i.e., </span>
   <span class="font10">Acad. </span>
   <span class="font10">Although </span>
   <span class="font10">Biol., </span>
   <span class="font10">EBOV, </span>
   <span class="font10">FAVIPIRAVIR </span>
   <span class="font10">IFNα, </span>
   <span class="font10">Model </span>
   <span class="font10">PKs </span>
   <span class="font10">Proc. </span>
   <span class="font10">absence </span>
   <span class="font10">administered </span>
   <span class="font10">and, </span>
   <span class="font10">approved </span>
   <span class="font10">best </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">capture </span>
   <span class="font10">case </span>
   <span class="font10">cells. </span>
   <span class="font10">conducted </span>
   <span class="font10">death, </span>
   <span class="font10">decline </span>
   <span class="font10">delay </span>
   <span class="font10">description </span>
   <span class="font10">different </span>
   <span class="font10">disease. </span>
   <span class="font10">due </span>
   <span class="font10">elimination </span>
   <span class="font10">emerging </span>
   <span class="font10">experiment </span>
   <span class="font10">experiments, </span>
   <span class="font10">find </span>
   <span class="font10">followed </span>
   <span class="font10">higher </span>
   <span class="font10">increasing </span>
   <span class="font10">infections </span>
   <span class="font10">infections. </span>
   <span class="font10">kinetic </span>
   <span class="font10">left </span>
   <span class="font10">levels, </span>
   <span class="font10">limiting </span>
   <span class="font10">main </span>
   <span class="font10">median </span>
   <span class="font10">need </span>
   <span class="font10">order </span>
   <span class="font10">over </span>
   <span class="font10">parameter </span>
   <span class="font10">polymerase </span>
   <span class="font10">possible </span>
   <span class="font10">primates </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">protection </span>
   <span class="font10">rapid </span>
   <span class="font10">reducing </span>
   <span class="font10">reduction </span>
   <span class="font10">refractory </span>
   <span class="font10">release </span>
   <span class="font10">rhesus </span>
   <span class="font10">set </span>
   <span class="font10">showed </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">survival. </span>
   <span class="font10">therapeutic </span>
   <span class="font10">there </span>
   <span class="font10">timing </span>
   <span class="font10">viremia, </span>
   <span class="font10">virus. </span>
   <span class="font10">viruses. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(iii) </span>
   <span class="font10">Based </span>
   <span class="font10">Consistent </span>
   <span class="font10">Feldmann, </span>
   <span class="font10">Guedj, </span>
   <span class="font10">IFN </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Lancet, </span>
   <span class="font10">Madelain, </span>
   <span class="font10">Natl. </span>
   <span class="font10">Nature, </span>
   <span class="font10">Pharmacometrics </span>
   <span class="font10">S., </span>
   <span class="font10">S.et </span>
   <span class="font10">Sci. </span>
   <span class="font10">V.et </span>
   <span class="font10">Virol., </span>
   <span class="font10">Warren, </span>
   <span class="font10">Zaire </span>
   <span class="font10">additional </span>
   <span class="font10">alEbola </span>
   <span class="font10">alEfficacy </span>
   <span class="font10">alFavipiravir </span>
   <span class="font10">aldehyde </span>
   <span class="font10">animals, </span>
   <span class="font10">antibodies </span>
   <span class="font10">assumed </span>
   <span class="font10">bold </span>
   <span class="font10">called </span>
   <span class="font10">cases </span>
   <span class="font10">characterize </span>
   <span class="font10">collected </span>
   <span class="font10">compartments </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">delayed </span>
   <span class="font10">done </span>
   <span class="font10">dynamic </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">extended </span>
   <span class="font10">fatality </span>
   <span class="font10">fever. </span>
   <span class="font10">four </span>
   <span class="font10">fully </span>
   <span class="font10">half�?life </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">identified </span>
   <span class="font10">impact </span>
   <span class="font10">instance </span>
   <span class="font10">last </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">macaques. </span>
   <span class="font10">modeled </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mortality </span>
   <span class="font10">outbreak, </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">performed </span>
   <span class="font10">postexposure </span>
   <span class="font10">potentiate </span>
   <span class="font10">primate </span>
   <span class="font10">process </span>
   <span class="font10">pt;} </span>
   <span class="font10">rather </span>
   <span class="font10">reduced </span>
   <span class="font10">reduces </span>
   <span class="font10">review </span>
   <span class="font10">same </span>
   <span class="font10">severe </span>
   <span class="font10">species </span>
   <span class="font10">strong </span>
   <span class="font10">study </span>
   <span class="font10">susceptible </span>
   <span class="font10">terms </span>
   <span class="font10">testing </span>
   <span class="font10">then </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatment. </span>
   <span class="font10">trials </span>
   <span class="font10">twice </span>
   <span class="font10">understand </span>
   <span class="font10">various </span>
   <span class="font10">very </span>
   <span class="font10">viruses </span>
   <span class="font10">viruses, </span>
   <span class="font10">vivo </span>
   <span class="font10">µg/mL, </span>
  </p>
 </body>
</html>
